Search Results - Peter Hollander

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases by Maysaa Abdulla, Christer Sundström, Cecilia Lindskog, Peter Hollander

    Published in Biomolecules (2023-01-01)
    Get full text
    Article


  2. 2

    LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients by Karin Paulsen, Millaray Marincevic, Lucia Cavelier, Peter Hollander, Rose-Marie Amini

    Published in Diagnostics (2022-06-01)
    Get full text
    Article


  3. 3

    High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome by Peter Hollander, Peter Kamper, Karin Ekstrom Smedby, Gunilla Enblad, Maja Ludvigsen, Julie Mortensen, Rose-Marie Amini, Stephen Hamilton-Dutoit, Francesco d'Amore, Daniel Molin, Ingrid Glimelius

    Published in Blood Advances (2017-08-01)
    Get full text
    Article


  4. 4

    MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and <i>TP53</i>/p53 – a Nordic Lymphoma Group study by Joana M. Rodrigues, Peter Hollander, Lina Schmidt, Eirinaios Gkika, Masoud Razmara, Darshan Kumar, Christian Geisler, Kirsten Grønbæk, Christian W. Eskelund, Riikka Räty, Arne Kolstad, Christer Sundström, Ingrid Glimelius, Anna Porwit, Mats Jerkeman, Sara Ek

    Published in Haematologica (2023-08-01)
    Get full text
    Article


Search Tools: